Free Trial

Barclays (BCS) Financials

Barclays logo
$17.65 -0.20 (-1.14%)
As of 01:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Barclays

Annual Income Statements for Barclays

This table shows Barclays' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
7,897 6,702 7,159 9,462 3,254 3,261 2,993 -1,498 2,566 -581
Consolidated Net Income / (Loss)
7,958 6,783 7,214 9,526 3,361 4,444 3,291 -973 3,489 918
Net Income / (Loss) Continuing Operations
7,392 7,012 7,950 9,526 3,361 4,444 3,291 1,993 2,760 -4.42
Total Pre-Tax Income
10,152 8,356 8,468 11,062 4,186 5,773 4,451 4,784 3,985 1,689
Total Revenue
33,541 32,339 30,139 29,619 29,726 28,664 25,057 25,316 26,467 32,481
Net Interest Income / (Expense)
16,197 16,195 12,768 10,899 11,092 12,465 11,545 13,300 13,001 15,633
Total Interest Income
47,988 44,696 23,062 15,174 16,241 20,480 18,525 18,414 17,941 20,563
Investment Securities Interest Income
47,988 44,696 23,062 15,174 16,241 20,480 18,525 18,414 17,941 20,563
Total Interest Expense
31,791 28,501 10,294 4,275 5,149 8,015 6,980 5,114 4,940 4,930
Long-Term Debt Interest Expense
31,791 28,501 10,294 4,275 5,149 8,015 6,980 5,114 4,940 4,930
Total Non-Interest Income
16,377 16,066 17,896 18,720 18,634 16,199 13,512 12,016 13,466 16,848
Trust Fees by Commissions
9,074 8,320 7,970 10,360 8,974 8,958 8,675 9,205 8,351 10,108
Other Service Charges
81 171 205 119 42 131 -1,870 -3,080 67 74
Net Realized & Unrealized Capital Gains on Investments
7,222 7,576 9,721 8,242 9,617 7,110 5,817 4,728 5,049 6,666
Total Non-Interest Expense
23,035 23,743 21,466 18,908 25,572 22,985 20,693 20,879 23,087 29,914
Salaries and Employee Benefits
15,834 16,080 13,915 14,375 14,217 14,066 14,123 15,265 14,778 17,443
Net Occupancy & Equipment Expense
4,444 5,218 4,148 - 4,538 - 3,758 3,984 - -
Other Operating Expenses
275 47 1,929 5,415 209 6,386 2,812 1,631 5,381 9,874
Impairment Charge
2,482 2,397 1,473 -882 6,607 2,534 - - 2,928 2,597
Nonoperating Income / (Expense), net
46 -11 7.25 351 31 94 88 347 605 -878
Income Tax Expense
2,194 1,572 1,255 1,536 825 1,329 1,161 2,791 1,225 1,693
Net Income / (Loss) Attributable to Noncontrolling Interest
-61 -82 -54 63 107 -106 -298 -525 -923 990
Basic Earnings per Share
$0.45 $0.35 $0.37 $0.37 $0.09 $0.14 $0.09 ($0.07) $19.70 ($1.90)
Weighted Average Basic Shares Outstanding
14.42B 15.15B 15.87B 16.75B 17.36B 17.32B 16.80B 16.80B - -
Diluted Earnings per Share
$0.44 $0.34 $0.36 $0.36 $0.09 $0.14 $0.09 ($0.10) $10.30 ($1.90)
Weighted Average Diluted Shares Outstanding
14.42B 15.15B 15.87B 16.75B 17.36B 17.32B 16.80B 16.80B - -
Weighted Average Basic & Diluted Shares Outstanding
14.42B 15.15B 15.87B 16.75B 17.36B 17.32B 16.80B 16.80B - -

Quarterly Income Statements for Barclays

No quarterly income statements for Barclays are available.


Annual Cash Flow Statements for Barclays

This table details how cash moves in and out of Barclays' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
-4,877 -20,934 23,652 66,236 59,448 -35,941 9,947 81,732 71,013 11,903
Net Cash From Operating Activities
818 -22,114 36,510 66,041 78,535 -665 11,705 82,014 13,925 22,598
Net Cash From Continuing Operating Activities
818 -22,114 23,333 66,041 78,535 -665 11,705 63,601 19,645 22,598
Net Income / (Loss) Continuing Operations
0.00 0.00 8,468 11,062 4,186 5,773 4,451 4,784 3,985 1,689
Provision For Loan Losses
626 614 2,082 632 - - 3,305 - - -
Depreciation Expense
2,171 2,736 2,157 2,803 2,368 2,014 1,606 1,676 1,556 1,791
Non-Cash Adjustments to Reconcile Net Income
5,949 2,440 -15,995 3,347 4,470 5,267 -3,812 6,642 -20,502 8,614
Changes in Operating Assets and Liabilities, net
-7,928 -27,905 26,620 48,198 67,511 -13,720 6,155 68,912 28,886 10,505
Net Cash From Investing Activities
-5,666 -6,053 -26,174 5,765 -25,096 -31,756 1,589 4,731 45,291 -9,654
Net Cash From Continuing Investing Activities
-5,666 -6,053 -2,005 5,765 -25,096 -31,756 1,589 4,731 45,291 -9,654
Purchase of Investment Securities
-5,666 -6,053 - -119,034 -145,332 -141,908 -141,677 -112,295 -80,306 -176,937
Net Cash From Financing Activities
0.00 0.00 841 144 3,731 914 -8,647 1,298 -1,625 -846
Net Cash From Continuing Financing Activities
0.00 0.00 841 144 3,731 914 -101 8,261 -1,280 -846
Repayment of Debt
0.00 0.00 -10,886 -11,181 -4,449 -4,304 -4,135 -1,862 -1,410 -819
Effect of Exchange Rate Changes
-29 7,233 12,476 -5,713 2,278 -4,435 5,300 -6,448 12,922 2,489

Quarterly Cash Flow Statements for Barclays

No quarterly cash flow statements for Barclays are available.


Annual Balance Sheets for Barclays

This table presents Barclays' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
1,900,941 1,882,762 1,828,094 1,868,785 1,843,045 1,510,895 1,443,802 1,530,893 1,496,816 1,650,578
Cash and Due from Banks
263,171 286,251 309,595 322,075 261,024 199,104 225,582 231,113 126,288 73,261
Restricted Cash
150,055 138,757 135,983 124,932 138,438 110,321 98,379 104,245 111,213 -
Trading Account Securities
575,945 549,785 526,790 552,969 587,796 455,074 416,241 476,354 614,852 607,797
Loans and Leases, Net of Allowance
346,239 358,182 764,109 834,844 826,940 717,306 676,710 691,372 618,503 937,071
Loans and Leases
5,927 3,306 427,608 492,315 480,270 453,832 418,775 534,289 521,513 823,845
Allowance for Loan and Lease Losses
-340,312 -354,876 -336,501 -342,529 -346,670 -263,474 -257,935 -157,083 -96,990 -113,227
Premises and Equipment, Net
4,513 4,354 4,367 4,799 5,512 5,585 3,230 3,474 3,486 5,111
Unearned Premiums Asset
4,086 4,673 5,728 - - - - - - -
Goodwill
10,361 9,932 9,950 10,882 10,855 10,758 10,157 10,603 9,533 12,117
Other Assets
27,596 21,750 71,571 13,046 12,480 12,747 13,480 13,732 12,941 10,802
Total Liabilities & Shareholders' Equity
1,900,941 1,882,762 1,828,094 1,868,785 1,843,045 1,510,895 1,443,780 1,530,893 1,496,816 1,650,595
Total Liabilities
1,810,187 1,791,185 1,744,449 1,774,229 1,751,703 1,423,890 1,362,527 1,441,713 1,408,762 1,553,530
Federal Funds Purchased and Securities Sold
49,352 53,012 168,997 171,746 122,873 120,431 128,499 153,531 118,070 138,803
Short-Term Debt
353,373 379,154 328,056 338,796 341,107 270,748 276,242 234,674 118,488 135,207
Bankers Acceptance Outstanding
133,009 119,891 117,059 107,151 116,663 89,232 86,022 92,054 99,508 -
Other Short-Term Payables
2,440 2,693 2,565 3,506 4,027 4,077 4,179 5,578 6,010 7,435
Unearned Premiums Liability
301 339 319 - - - - - - -
Separate Account Business Liabilities
14,926 13,373 13,796 17,225 22,317 24,058 26,192 32,186 28,851 31,637
Other Long-Term Liabilities
439,084 412,761 454,517 434,152 487,363 363,931 337,977 384,667 555,235 538,429
Total Equity & Noncontrolling Interests
90,753 91,576 83,645 94,555 91,341 87,005 81,253 89,180 88,054 97,066
Total Preferred & Common Equity
89,927 90,735 82,476 93,220 89,860 85,374 79,695 86,329 80,044 88,144
Total Common Equity
89,927 90,735 82,476 93,220 89,860 85,374 79,695 86,329 80,044 88,144
Common Stock
5,241 5,464 5,281 6,124 6,333 6,087 5,492 29,780 26,950 31,812
Retained Earnings
70,153 68,473 63,799 68,157 62,177 58,574 55,367 37,198 37,671 45,717
Other Equity Adjustments
14,533 16,798 13,396 18,939 21,350 20,712 18,836 19,350 15,423 10,615
Noncontrolling Interest
826 841 1,169 1,335 1,482 1,631 1,558 2,852 8,010 8,922

Quarterly Balance Sheets for Barclays

No quarterly balance sheets for Barclays are available.


Annual Metrics And Ratios for Barclays

This table displays calculated financial ratios and metrics derived from Barclays' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
3.72% 7.30% 1.76% -0.36% 3.70% 14.40% -1.02% -4.35% -18.51% 0.00%
EBITDA Growth
11.87% 4.63% -19.85% 107.18% -15.22% 28.87% -2.34% 23.82% 13.28% 0.00%
EBIT Growth
22.22% -0.89% -19.02% 157.82% -26.85% 30.16% -1.64% 31.22% 31.69% 0.00%
NOPAT Growth
16.63% -5.76% -21.86% 176.50% -23.70% 35.53% 74.56% -21.08% 34,939.64% 0.00%
Net Income Growth
17.33% -5.97% -24.27% 183.41% -24.38% 35.06% 438.33% -127.87% 280.05% 0.00%
EPS Growth
27.10% -4.75% 1.10% 313.95% -39.01% 53.26% 191.09% -100.98% 642.11% 0.00%
Operating Cash Flow Growth
103.70% -160.57% -44.72% -15.91% 11,906.42% -105.68% -85.73% 488.96% -38.38% 0.00%
Free Cash Flow Firm Growth
166.10% -281.02% 246.85% 111.66% -1,825.38% 113.59% 73.64% -511.56% 0.00% 0.00%
Invested Capital Growth
-5.65% 14.34% -5.00% 0.21% 20.88% 0.07% 10.39% 56.80% -11.07% 0.00%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
EBITDA Margin
37.80% 35.04% 35.94% 45.62% 21.94% 26.84% 23.83% 24.15% 18.65% 13.42%
EBIT Margin
31.32% 26.58% 28.78% 36.16% 13.98% 19.81% 17.41% 17.52% 12.77% 7.90%
Profit (Net Income) Margin
23.73% 20.97% 23.93% 32.16% 11.31% 15.50% 13.13% -3.84% 13.18% 2.83%
Tax Burden Percent
78.39% 81.18% 85.18% 86.11% 80.29% 76.98% 73.93% -20.33% 87.55% 54.36%
Interest Burden Percent
96.63% 97.20% 97.63% 103.28% 100.76% 101.66% 102.01% 107.83% 117.88% 65.79%
Effective Tax Rate
21.61% 18.82% 14.82% 13.89% 19.71% 23.02% 26.07% 58.35% 30.74% 100.26%
Return on Invested Capital (ROIC)
1.73% 1.54% 1.71% 2.13% 0.84% 1.22% 0.95% 0.70% 1.07% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
1.74% 1.54% 1.71% 2.22% 0.85% 1.25% 0.97% -0.90% 1.97% 0.68%
Return on Net Nonoperating Assets (RNNOA)
7.00% 6.20% 6.39% 8.12% 2.92% 4.06% 2.91% -1.79% 2.70% 0.95%
Return on Equity (ROE)
8.73% 7.74% 8.10% 10.25% 3.77% 5.28% 3.86% -1.10% 3.77% 0.95%
Cash Return on Invested Capital (CROIC)
7.55% -11.84% 6.83% 1.92% -18.06% 1.16% -8.93% -43.54% 12.79% 0.00%
Operating Return on Assets (OROA)
0.56% 0.46% 0.47% 0.58% 0.25% 0.38% 0.29% 0.29% 0.21% 0.16%
Return on Assets (ROA)
0.42% 0.37% 0.39% 0.51% 0.20% 0.30% 0.22% -0.06% 0.22% 0.06%
Return on Common Equity (ROCE)
8.65% 7.65% 7.98% 10.09% 3.70% 5.18% 3.76% -1.03% 3.43% 0.86%
Return on Equity Simple (ROE_SIMPLE)
8.85% 7.48% 8.75% 10.22% 3.74% 5.21% 4.13% -1.13% 4.36% 1.04%
Net Operating Profit after Tax (NOPAT)
7,922 6,792 7,207 9,223 3,336 4,372 3,226 1,848 2,341 -6.72
NOPAT Margin
23.62% 21.00% 23.91% 31.14% 11.22% 15.25% 12.87% 7.30% 8.85% -0.02%
Net Nonoperating Expense Percent (NNEP)
-0.01% 0.00% 0.00% -0.09% -0.01% -0.03% -0.03% 1.60% -0.91% -0.68%
SG&A Expenses to Revenue
60.46% 65.86% 59.93% 48.53% 63.09% 49.07% 71.36% 76.04% 55.83% 53.70%
Operating Expenses to Revenue
68.68% 73.42% 71.22% 63.84% 86.02% 80.19% 82.59% 82.48% 87.23% 92.10%
Earnings before Interest and Taxes (EBIT)
10,506 8,596 8,674 10,711 4,154 5,679 4,363 4,436 3,381 2,567
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
12,678 11,332 10,831 13,514 6,523 7,693 5,970 6,113 4,937 4,358
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.55 0.31 0.34 0.00 0.31 0.37 0.30 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.62 0.35 0.39 0.00 0.35 0.43 0.35 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.48 0.88 0.94 0.00 0.93 1.11 0.96 0.00 0.00 0.00
Price to Earnings (P/E)
6.26 4.25 3.96 0.00 8.51 9.78 8.07 0.00 0.00 0.00
Dividend Yield
5.27% 5.31% 4.63% 1.92% 6.51% 4.71% 4.15% 1.88% 9.01% 4.43%
Earnings Yield
15.96% 23.54% 25.25% 0.00% 11.75% 10.22% 12.39% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
3.89 4.14 3.92 3.58 3.73 3.11 3.40 2.63 1.35 1.39
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
4.02 4.04 3.74 3.66 3.43 3.25 3.00 1.99 1.37 1.39
Leverage Ratio
20.75 21.18 20.75 19.97 18.81 17.56 17.45 17.08 17.00 17.00
Compound Leverage Factor
20.05 20.58 20.25 20.62 18.95 17.85 17.81 18.42 20.04 11.19
Debt to Total Capital
79.57% 80.55% 79.68% 78.18% 78.88% 75.68% 77.27% 72.46% 57.37% 58.21%
Short-Term Debt to Total Capital
79.57% 80.55% 79.68% 78.18% 78.88% 75.68% 77.27% 72.46% 57.37% 58.21%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.19% 0.18% 0.28% 0.31% 0.34% 0.46% 0.44% 0.88% 3.88% 3.84%
Common Equity to Total Capital
20.25% 19.28% 20.03% 21.51% 20.78% 23.86% 22.29% 26.66% 38.75% 37.95%
Debt to EBITDA
27.87 33.46 30.29 25.07 52.30 35.19 46.27 38.39 24.00 31.03
Net Debt to EBITDA
-4.72 -4.05 -10.85 -8.01 -8.95 -5.03 -7.99 -16.47 -24.11 14.22
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
44.61 55.82 45.52 36.73 102.26 61.93 85.64 126.99 50.61 -20,118.59
Net Debt to NOPAT
-7.56 -6.75 -16.31 -11.73 -17.49 -8.85 -14.79 -54.48 -50.83 -9,217.56
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.91% 1.15% 1.41% 1.52% 1.75% 1.90% 2.59% 6.13% 9.15% 9.19%
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
34,526 -52,237 28,857 8,320 -71,359 4,136 -30,437 -115,465 28,055 0.00
Operating Cash Flow to CapEx
0.00% 0.00% 1,731.44% 2,844.13% 4,343.28% -28.74% 663.87% 5,175.70% 836.62% 998.96%
Free Cash Flow to Firm to Interest Expense
1.09 -1.83 2.80 1.95 -13.86 0.52 -4.36 -22.58 5.68 0.00
Operating Cash Flow to Interest Expense
0.03 -0.78 3.55 15.45 15.25 -0.08 1.68 16.04 2.82 4.58
Operating Cash Flow Less CapEx to Interest Expense
0.03 -0.78 3.34 14.90 14.90 -0.37 1.42 15.73 2.48 4.13
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Fixed Asset Turnover
7.57 7.42 6.58 5.75 5.36 6.50 7.48 7.27 6.16 6.36
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
444,126 470,730 411,701 433,351 432,448 357,753 357,517 323,854 206,542 232,255
Invested Capital Turnover
0.07 0.07 0.07 0.07 0.08 0.08 0.07 0.10 0.12 0.14
Increase / (Decrease) in Invested Capital
-26,604 59,029 -21,650 903 74,695 236 33,663 117,313 -25,714 0.00
Enterprise Value (EV)
-9,555 -16,541 -87,995 0.00 -29,181 -5,151 -22,003 0.00 0.00 0.00
Market Capitalization
49,472 28,473 28,359 0.00 27,692 31,894 24,158 0.00 0.00 0.00
Book Value per Share
$5.93 $5.72 $4.92 $5.56 $5.18 $5.08 $4.74 $5.14 $0.00 $0.00
Tangible Book Value per Share
$5.25 $5.09 $4.33 $4.92 $4.55 $4.44 $4.14 $4.51 $0.00 $0.00
Total Capital
444,126 470,730 411,701 433,351 432,448 357,753 357,495 323,854 206,542 232,273
Total Debt
353,373 379,154 328,056 338,796 341,107 270,748 276,242 234,674 118,488 135,207
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-59,854 -45,854 -117,522 -108,211 -58,355 -38,676 -47,719 -100,685 -119,013 61,947
Capital Expenditures (CapEx)
0.00 0.00 2,109 2,322 1,808 2,315 1,763 1,585 1,664 2,262
Net Nonoperating Expense (NNE)
-36 9.31 -6.17 -302 -25 -72 -65 2,821 -1,148 -925
Net Nonoperating Obligations (NNO)
353,373 379,154 328,056 338,796 341,107 270,748 276,264 234,674 118,488 135,190
Total Depreciation and Amortization (D&A)
2,171 2,736 2,157 2,803 2,368 2,014 1,606 1,676 1,556 1,791
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.45 $0.28 $0.31 $0.00 $0.09 $0.29 $18.80 ($10.30) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
14.42B 15.15B 15.87B 0.00 17.36B 17.32B 16.80B 16.80B 0.00 0.00
Adjusted Diluted Earnings per Share
$0.44 $0.27 $0.30 $0.00 $0.09 $0.14 $9.20 ($10.10) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
14.42B 15.15B 15.87B 0.00 17.36B 17.32B 16.80B 16.80B 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
14.42B 15.15B 15.87B 0.00 17.36B 17.32B 16.80B 16.80B 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
9,867 8,738 8,462 8,464 8,641 6,322 3,226 3,105 4,369 3,615
Normalized NOPAT Margin
29.42% 27.02% 28.08% 28.58% 29.07% 22.06% 12.87% 12.27% 16.51% 11.13%
Pre Tax Income Margin
30.27% 25.84% 28.10% 37.35% 14.08% 20.14% 17.76% 18.90% 15.06% 5.20%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.33 0.30 0.84 2.51 0.81 0.71 0.63 0.87 0.68 0.52
NOPAT to Interest Expense
0.25 0.24 0.70 2.16 0.65 0.55 0.46 0.36 0.47 0.00
EBIT Less CapEx to Interest Expense
0.33 0.30 0.64 1.96 0.46 0.42 0.37 0.56 0.35 0.06
NOPAT Less CapEx to Interest Expense
0.25 0.24 0.50 1.61 0.30 0.26 0.21 0.05 0.14 -0.46
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 33.12% 19.27% 38.03% 57.01% 64.19% -176.81% 46.11% 240.13%
Augmented Payout Ratio
0.00% 0.00% 94.31% 21.50% 80.94% 136.55% 202.86% -362.78% 102.23% 240.13%

Quarterly Metrics And Ratios for Barclays

No quarterly metrics and ratios for Barclays are available.


Frequently Asked Questions About Barclays' Financials

When does Barclays's fiscal year end?

According to the most recent income statement we have on file, Barclays' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Barclays' net income changed over the last 9 years?

Barclays' net income appears to be on an upward trend, with a most recent value of $7.96 billion in 2024, rising from $918.13 million in 2015. The previous period was $6.78 billion in 2023. View Barclays' forecast to see where analysts expect Barclays to go next.

How has Barclays revenue changed over the last 9 years?

Over the last 9 years, Barclays' total revenue changed from $32.48 billion in 2015 to $33.54 billion in 2024, a change of 3.3%.

How much debt does Barclays have?

Barclays' total liabilities were at $1.81 trillion at the end of 2024, a 1.1% increase from 2023, and a 16.5% increase since 2015.

How much cash does Barclays have?

In the past 9 years, Barclays' cash and equivalents has ranged from $73.26 billion in 2015 to $322.07 billion in 2021, and is currently $263.17 billion as of their latest financial filing in 2024.

How has Barclays' book value per share changed over the last 9 years?

Over the last 9 years, Barclays' book value per share changed from 0.00 in 2015 to 5.93 in 2024, a change of 593.4%.



This page (NYSE:BCS) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners